Statements (19)
| Predicate | Object |
|---|---|
| gptkbp:instanceOf |
gptkb:drug
|
| gptkbp:activeIngredient |
gptkb:ranitidine
|
| gptkbp:drugClass |
H2 receptor antagonist
|
| https://www.w3.org/2000/01/rdf-schema#label |
Zinetac
|
| gptkbp:manufacturer |
GlaxoSmithKline
|
| gptkbp:marketedIn |
gptkb:India
|
| gptkbp:retired |
NDMA contamination concerns
|
| gptkbp:routeOfAdministration |
oral
intravenous |
| gptkbp:sideEffect |
diarrhea
constipation dizziness headache |
| gptkbp:status |
withdrawn in many countries
|
| gptkbp:usedFor |
treatment of heartburn
treatment of gastroesophageal reflux disease treatment of peptic ulcer |
| gptkbp:bfsParent |
gptkb:GSK_India
|
| gptkbp:bfsLayer |
6
|